Abstract
Improvements in patient global assessment of disease severity, plaque psoriasis and psoriatic arthritis pain, and pruritus with adalimumab: Subanalysis of the first 16 weeks of reveal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have